Physician

Emily Katherine Grieshaber, M.D.

According to 2025 Medicare claims, Emily Grieshaber, M.D. (NPI: 1265605158) practices dermatology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is THE DERMATOLOGY CLINIC OF ST TAMMANY II, LLC (NPI: 1356421010; TIN: 842737785) and primary practice location at 70433-2422.

Grieshaber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 534 traditional Medicare patients, billed 3,830 HCPCS/CPT codes, and received $168,795 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 874 prescription claims across 335 beneficiaries totaling $386,974 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 95 records totaling $1,819. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $100,258 to $386,974. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$84K$169K2015 Medicare payment: $122,858 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $146,648 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $137,931 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $108,937 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $130,971 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $130,955 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $124,756 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $133,306 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $120,789 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $168,795 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155542,969$122,858
20166043,402$146,648
20175943,189$137,931
20184832,663$108,937
20195243,122$130,971
20205073,133$130,955
20214552,904$124,756
20224833,360$133,306
20234493,150$120,789
20245343,830$168,795

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$193K$387K2015 Drug cost: $100,258 (USD; Tot_Drug_Cst)2016 Drug cost: $121,603 (USD; Tot_Drug_Cst)2017 Drug cost: $161,423 (USD; Tot_Drug_Cst)2018 Drug cost: $168,870 (USD; Tot_Drug_Cst)2019 Drug cost: $171,736 (USD; Tot_Drug_Cst)2020 Drug cost: $157,012 (USD; Tot_Drug_Cst)2021 Drug cost: $93,640 (USD; Tot_Drug_Cst)2022 Drug cost: $90,557 (USD; Tot_Drug_Cst)2023 Drug cost: $280,693 (USD; Tot_Drug_Cst)2024 Drug cost: $386,974 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015336865$100,258
2016360915$121,603
2017314820$161,423
2018302660$168,870
2019292660$171,736
2020318796$157,012
2021284647$93,640
2022282611$90,557
2023295688$280,693
2024335874$386,974

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths195222$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more382588$58
11102Biopsy of related skin growth, first growth186213$51
17000Destruction of precancer skin growth, 1 growth297421$30
17003Destruction of precancer skin growth, 2-14 growths2121,296$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab32896$120,524
OtezlaApremilast19570$90,088
Clobetasol PropionateClobetasol Propionate611,699$2,498
KetoconazoleKetoconazole1213,357$1,877
FluocinonideFluocinonide411,088$1,580

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.95$1,819ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emily Katherine Grieshaber, M.D.?

Tedicare shows public-source Medicare data for Emily Katherine Grieshaber, M.D. (NPI 1265605158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Katherine Grieshaber, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emily Katherine Grieshaber, M.D.?

Emily Katherine Grieshaber, M.D. is linked to THE DERMATOLOGY CLINIC OF ST TAMMANY II, LLC (billing NPI 1356421010) in the available physician profile data.

Does Emily Katherine Grieshaber, M.D. have Open Payments data?

Emily Katherine Grieshaber, M.D. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.